HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Antiseptic effect of vicenin-2 and scolymoside from Cyclopia subternata (honeybush) in response to HMGB1 as a late sepsis mediator in vitro and in vivo.

Abstract
Cyclopia subternata is a medicinal plant commonly used in traditional medicine to relieve pain. In this study, we investigated the antiseptic effects and underlying mechanisms of vicenin-2 and scolymoside, which are 2 active compounds from C. subternata that act against high mobility group box 1 (HMGB1)-mediated septic responses in human umbilical vein endothelial cells (HUVECs) and mice. The antiseptic activities of vicenin-2 and scolymoside were determined by measuring permeability, neutrophil adhesion and migration, and activation of proinflammatory proteins in HMGB1-activated HUVECs and mice. According to the results, vicenin-2 and scolymoside effectively inhibited lipopolysaccharide-induced release of HMGB1, and suppressed HMGB1-mediated septic responses such as hyperpermeability, the adhesion and migration of leukocytes, and the expression of cell adhesion molecules. In addition, vicenin-2 and scolymoside suppressed the production of tumor necrosis factor-α and interleukin 6, and activation of nuclear factor-κB and extracellular regulated kinases 1/2 by HMGB1. Collectively, these results indicate that vicenin-2 and scolymoside could be a potential therapeutic agents for the treatment of various severe vascular inflammatory diseases via inhibition of the HMGB1 signaling pathway.
AuthorsWonhwa Lee, Eun-Kyung Yoon, Kyung-Min Kim, Dong Ho Park, Jong-Sup Bae
JournalCanadian journal of physiology and pharmacology (Can J Physiol Pharmacol) Vol. 93 Issue 8 Pg. 709-20 (Aug 2015) ISSN: 1205-7541 [Electronic] Canada
PMID26243020 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Anti-Infective Agents, Local
  • Anti-Inflammatory Agents
  • Glucosides
  • HMGB1 Protein
  • HMGB1 protein, human
  • Inflammation Mediators
  • Lipopolysaccharides
  • apigenin-6,8-di-C-glycopyranoside
  • lipopolysaccharide, Escherichia coli O111 B4
  • scolymoside
  • Apigenin
  • Luteolin
Topics
  • Animals
  • Anti-Infective Agents, Local (pharmacology)
  • Anti-Inflammatory Agents (pharmacology)
  • Apigenin (isolation & purification, pharmacology)
  • Cell Adhesion (drug effects)
  • Cell Membrane Permeability (drug effects)
  • Cell Movement (drug effects)
  • Cells, Cultured
  • Coculture Techniques
  • Cyclopia Plant (chemistry)
  • Glucosides (isolation & purification, pharmacology)
  • HMGB1 Protein (antagonists & inhibitors, pharmacology)
  • Human Umbilical Vein Endothelial Cells (drug effects, metabolism)
  • Humans
  • Inflammation Mediators (metabolism)
  • Lipopolysaccharides (pharmacology)
  • Luteolin (isolation & purification, pharmacology)
  • Male
  • Mice, Inbred C57BL
  • Neutrophils (drug effects, metabolism)
  • Phytotherapy
  • Plants, Medicinal
  • Sepsis (drug therapy, metabolism, microbiology)
  • Signal Transduction (drug effects)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: